PubRank

P Romero

Author PubWeight™ 195.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intrinsically disordered protein. J Mol Graph Model 2001 8.54
2 The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science 2001 6.90
3 BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999 6.27
4 Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996 6.02
5 Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994 4.20
6 Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform 2000 3.47
7 Shift in the prevalent human rotavirus detected by ribonucleic acid segment differences. Infect Immun 1980 3.34
8 T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J Exp Med 1991 3.08
9 High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 1999 2.98
10 Presence of two distinct types of rotavirus in infants and young children hospitalized with acute gastroenteritis in Mexico City, 1977. J Infect Dis 1979 2.84
11 Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J Immunol 1998 2.68
12 CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 1991 2.67
13 High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998 2.58
14 Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac Symp Biocomput 1998 2.37
15 Clinical management of field worker organophosphate poisoning. West J Med 1985 2.27
16 A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 1988 2.26
17 CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 1995 2.15
18 Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature 1987 1.85
19 Denitrifying Pseudomonas aeruginosa: some parameters of growth and active transport. Appl Environ Microbiol 1978 1.79
20 Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J Immunol 2001 1.77
21 Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 1996 1.75
22 T cell assays and MIATA: the essential minimum for maximum impact. Immunity 2012 1.74
23 Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J Immunol 2000 1.68
24 Trypsin activation pathway of rotavirus infectivity. J Virol 1996 1.63
25 A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 1987 1.61
26 The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med 1992 1.56
27 Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial. J Immunol Methods 2000 1.53
28 CD4+ cytolytic T cell clone confers protection against murine malaria. J Exp Med 1990 1.51
29 Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res 2000 1.47
30 Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol 1985 1.46
31 OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat Immunol 2000 1.43
32 Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother 2010 1.36
33 Simulation of wheat growth and development based on organ-level photosynthesis and assimilate allocation. J Exp Bot 2010 1.33
34 Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol 1984 1.32
35 Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. J Immunol 2000 1.31
36 Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity. Cancer Res 2001 1.31
37 Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc Natl Acad Sci U S A 2001 1.31
38 Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J Immunol 1999 1.28
39 CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol 1999 1.26
40 Entry of rotaviruses is a multistep process. Virology 1999 1.25
41 Comparison of human rotaviruses isolated in Mexico City and in Santiago, Chile, by electrophoretic migration of their double-stranded ribonucleic acid genome segments. Infect Immun 1980 1.24
42 Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J Immunol 2001 1.24
43 Relative localization of viroplasmic and endoplasmic reticulum-resident rotavirus proteins in infected cells. Arch Virol 2000 1.22
44 Alkaline phosphatase isoenzymes in diagnosis. Quad Sclavo Diagn 1972 1.22
45 Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry. Bone Marrow Transplant 1999 1.20
46 Cyclic AMP and adenylate cyclase activators stimulate Trypanosoma cruzi differentiation. Exp Parasitol 1988 1.17
47 Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells. J Immunol 1990 1.17
48 The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol 2000 1.16
49 The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides. Int Immunol 1991 1.16
50 Growth of Thiobacillus ferrooxidans on Elemental Sulfur. Appl Environ Microbiol 1987 1.16
51 Integrin alpha2beta1 mediates the cell attachment of the rotavirus neuraminidase-resistant variant nar3. Virology 2000 1.16
52 Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J Exp Med 1999 1.14
53 Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. J Immunol 2000 1.13
54 CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding. J Exp Med 1996 1.11
55 A functional screen for germ line p53 mutations based on transcriptional activation. Cancer Res 1992 1.10
56 Rotavirus YM gene 4: analysis of its deduced amino acid sequence and prediction of the secondary structure of the VP4 protein. J Virol 1991 1.09
57 Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide. Clin Cancer Res 2001 1.08
58 Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. J Immunol Methods 2000 1.08
59 In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 1999 1.08
60 Structural analysis of TCR-ligand interactions studied on H-2Kd-restricted cloned CTL specific for a photoreactive peptide derivative. Immunity 1995 1.07
61 T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J Immunol Methods 1992 1.06
62 Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes. J Immunol 1991 1.04
63 [Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population]. Med Clin (Barc) 2001 1.04
64 Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope. Int J Radiat Oncol Biol Phys 1999 1.03
65 Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J Immunol 2000 1.03
66 Comparative study of different methods for detection and enumeration of Salmonella spp. in natural waters. J Appl Bacteriol 1986 1.03
67 The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 1993 1.02
68 Siderosilicosis due to photocopier toner dust. Lancet 1994 1.02
69 The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells. J Immunol 2001 1.01
70 Photoaffinity labeling of the T cell receptor on cloned cytotoxic T lymphocytes by covalent photoreactive ligand. J Biol Chem 1994 1.01
71 Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells. Eur J Immunol 2001 1.00
72 HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT. Parasite Immunol 2000 1.00
73 Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma. Cancer Res 2001 1.00
74 Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide. J Immunol 1998 0.99
75 The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100. J Invest Dermatol 1996 0.99
76 Rotavirus gastroenteritis in hospitalized infants and young children in Mexico City. Rev Latinoam Microbiol 1980 0.99
77 The receptor interaction region of Tyk2 contains a motif required for its nuclear localization. J Biol Chem 2001 0.99
78 Differential stability of antigenic MHC class I-restricted synthetic peptides. J Immunol 1991 0.98
79 Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. Int Immunol 1999 0.98
80 Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses. Eur J Immunol 1994 0.96
81 Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes. Cancer Res 2001 0.96
82 Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. Cancer Res 1999 0.96
83 Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. Cancer Res 1997 0.96
84 Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients. Int Immunopharmacol 2001 0.95
85 Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin Exp Immunol 1999 0.95
86 Resistance to antibiotics and heavy metals of Pseudomonas aeruginosa isolated from natural waters. J Appl Bacteriol 1990 0.94
87 Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. J Immunol 1999 0.93
88 Clinical confirmation of organophosphate poisoning by serial cholinesterase analyses. Arch Intern Med 1987 0.93
89 Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue. J Immunol 2000 0.93
90 Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma. Int J Cancer 2001 0.93
91 Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype. Int J Cancer 1998 0.93
92 Evaluation of different plating media used in the isolation of salmonellas from environmental samples. J Appl Bacteriol 1989 0.92
93 The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients. Clin Transl Oncol 2009 0.92
94 Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing. Eur J Immunol 2001 0.91
95 Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice. Mucosal Immunol 2012 0.90
96 Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. Cancer Res 2001 0.90
97 Potential target antigens for immunotherapy in human pancreatic cancer. Cancer Lett 2007 0.90
98 An antigen-targeted approach to adoptive transfer therapy of cancer. Cancer Res 1999 0.90
99 Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells. Eur J Immunol 2000 0.90
100 A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics 1996 0.89
101 A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy. J Immunol 2001 0.88
102 Specific binding of antigenic peptides to cell-associated MHC class I molecules. Nature 1991 0.88
103 Antibiotic resistance of Salmonella strains isolated from natural polluted waters. J Appl Bacteriol 1990 0.88
104 Comparative study of selective media for enumeration of Pseudomonas aeruginosa from water by membrane filtration. Appl Environ Microbiol 1986 0.87
105 Differential expression of HLA-A*02 subtypes in Colombian Blacks and Mestizos. Tissue Antigens 1998 0.87
106 Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur J Immunol 1994 0.87
107 Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy. Clin Exp Immunol 2005 0.87
108 Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax. J Immunol 1987 0.87
109 [Veracity of smokers' reports of abstinence at smoking cessation clinics]. Arch Bronconeumol 2005 0.86
110 Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction. J Immunol 2001 0.86
111 Early events of rotavirus infection: the search for the receptor(s). Novartis Found Symp 2001 0.85
112 Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line. Clin Cancer Res 1997 0.85
113 Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes. Eur J Immunol 2000 0.85
114 Net ATP synthesis by running the red cell calcium pump backwards. Experientia 1979 0.84
115 Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet Cytogenet 1987 0.84
116 Highly diverse T cell recognition of a single Plasmodium berghei peptide presented by a series of mutant H-2Kd molecules. J Immunol 1992 0.83
117 Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia. Bone Marrow Transplant 1999 0.83
118 Amino acid identity and/or position determines the proteasomal cleavage of the HLA-A*0201-restricted peptide tumor antigen MAGE-3271-279. J Biol Chem 2000 0.83
119 Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy. J Clin Oncol 1988 0.83
120 Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses. Cell Immunol 1981 0.82
121 Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments. Cancer Immun 2001 0.82
122 Subcellular localization of the melanoma-associated protein Melan-AMART-1 influences the processing of its HLA-A2-restricted epitope. J Biol Chem 2001 0.82
123 Neutralizing antibody immune response in children with primary and secondary rotavirus infections. Clin Diagn Lab Immunol 1994 0.81
124 MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motif. Int Immunol 1993 0.81
125 N-acetyl-L-cysteine exhibits antitumoral activity by increasing tumor necrosis factor alpha-dependent T-cell cytotoxicity. Blood 1997 0.81
126 Indices of respiratory muscle endurance in healthy subjects. Respiration 1998 0.81
127 Design of the nutritional therapy for overweight and obese Spanish adolescents conducted by registered dieticians: the EVASYON study. Nutr Hosp 2012 0.80
128 Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution. J Exp Med 1991 0.80
129 A comparison of microbial bioassays for the detection of metal toxicity. Arch Environ Contam Toxicol 1993 0.80
130 CD8+ T-cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria. Immunol Lett 1995 0.79
131 The interaction of antigenic peptides with the H-2Kd MHC class I molecule. Semin Immunol 1993 0.79
132 HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44. J Biol Chem 1996 0.79
133 The 2001 epidemic of foot-and-mouth disease in the United Kingdom: epidemiological and meteorological case studies. Vet Rec 2005 0.78
134 Surgical complications in abdominal tumor surgery in children. Experiences at a single oncological center. Eur J Pediatr Surg 2009 0.78
135 [Benign familial hyperphosphatasemia: apropos of a case]. Rev Clin Esp 1987 0.78
136 [Community-acquired pneumonia in the elderly: prognostic factors]. Arch Bronconeumol 2002 0.78
137 [Elbow dislocation in childhood. Long-term observational study]. Unfallchirurg 2012 0.78
138 Evaluation of several selective media for recovery of Aeromonas hydrophila from polluted waters. Appl Environ Microbiol 1988 0.77
139 Most residues on the floor of the antigen binding site of the class I MHC molecule H-2Kd influence peptide presentation. Int Immunol 1992 0.77
140 Effect of elastase on oscillation mechanics of lung parenchymal strips. J Appl Physiol (1985) 1994 0.77
141 Validated HPLC method for the determination of ranitidine in plasma. Pharmazie 2003 0.77
142 Attachment site of grafted SCN influences precision of restored circadian rhythm. J Biol Rhythms 1997 0.77
143 Educational intervention to prevent pesticide-induced illness of field workers. J Fam Pract 1984 0.76
144 CDC group IV c-2 bacteremia in stem cell transplant recipients. Bone Marrow Transplant 1998 0.75
145 Molecular characterization of HLA class I in Colombians carrying HLA-A2: high allelic diversity and frequency of heterozygotes at the HLA-B locus. Tissue Antigens 1999 0.75
146 Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. Bull World Health Organ 1990 0.75
147 [Neutropenia and fever in the patient with cancer]. An Sist Sanit Navar 2004 0.75
148 Reversion of the steroid-induced decrease of serum osteocalcin with sodium fluoride. Clin Rheumatol 1991 0.75
149 [Diabetes mellitus in some populations of the State of Mérida, Venezuela]. Acta Cient Venez 1980 0.75
150 Asthma and other obstructive lung diseases. Lancet 1987 0.75
151 Human tumor immunotherapy. New opportunities as well as new challenges. Adv Exp Med Biol 1998 0.75
152 IL-2/LAK cell treatment for advanced cancers with emphasis on a novel administration. W V Med J 1991 0.75
153 Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis. Adv Perit Dial 2001 0.75
154 Design and performance of a new medium for the quantitative recovery of Staphylococcus aureus from recreational waters. J Appl Bacteriol 1987 0.75
155 Clip migration in clipped intestinal non-perforating anastomosis (CINPA). Eur J Pediatr Surg 2010 0.75
156 [Visceral larva migrans (clinical case)]. Rev Chil Pediatr 1980 0.75
157 [Image-guided brachytherapy]. An Sist Sanit Navar 2009 0.75
158 [Electroencephalographic changes in acute diffuse glomerulonephritis]. Rev Chil Pediatr 1983 0.75
159 [Localized scleroderma in children. Analysis of 5 cases]. Rev Chil Pediatr 1989 0.75
160 Aminophylline for morning dips in chronic asthma. Lancet 1984 0.75
161 [Comparative study of the activity of trimethoprim-sulfamethopyrazine and nitrofurantoin in urinary infections of children]. Rev Chil Pediatr 1986 0.75
162 [The clinical application of intensity-modulated radiation therapy]. An Sist Sanit Navar 2009 0.75
163 Gas physical properties and respiratory system resistance measured by flow interruption. Respir Physiol 1991 0.75
164 [Complicated sinusitis in a diabetic patient]. Enferm Infecc Microbiol Clin 1997 0.75
165 [In vitro effect of different antibiotics and chemical substances on 90 strains of Pseudomonas savastanoi]. Microbiol Esp 1969 0.75
166 [Epidemiological aspects of gastroenteritis dut to Rotavirus]. Bol Med Hosp Infant Mex 1978 0.75
167 Clinical confirmation of organophosphate poisoning of agricultural workers. Am J Ind Med 1986 0.75
168 [Malign obstruction of the superior vena cava]. An Sist Sanit Navar 2004 0.75
169 Comments on "Persistence of symptoms after mild to moderate acute organophosphate poisoning among 19 farm field workers" by Whorton and Obrinsky. J Toxicol Environ Health 1984 0.75
170 C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies. Blood 1986 0.75
171 Chronopharmacokinetics of theophylline administered as a controlled-release tablet. Int J Clin Pharmacol Ther 1996 0.75
172 [Existence of 2 types of Rotavirus associated with acute gastroenteritis in children]. Bol Med Hosp Infant Mex 1978 0.75
173 [Diagnosis of Rotavirus using viral RNA electrophoresis]. Bol Med Hosp Infant Mex 1978 0.75
174 [Intestinal protozoan parasitism in children from the bay of Cádiz]. Rev Sanid Hig Publica (Madr) 1992 0.75
175 Recognition of tumor-associated antigens by T-lymphocytes: perspectives for peptide-based vaccines. Ann Oncol 1996 0.75
176 Proceedings: SGOT and CPK isoenzymes in clinical medicine. Quad Sclavo Diagn 1973 0.75
177 Isolation of Salmonella using three selective enrichment broths from sausages naturally contaminated. Its relationship with other microorganisms that produce food toxi-infections. Zentralbl Bakteriol Mikrobiol Hyg B 1987 0.75
178 Differential roles of T cell receptor alpha and beta chains in ligand binding among H-2Kd-restricted cytolytic T lymphocyte clones specific for a photoreactive Plasmodium berghei circumsporozoite peptide derivative. J Biol Chem 1997 0.75
179 Hyperfractionated radiotherapy and concomitant cisplatin for locally advanced laryngeal and hypopharyngeal carcinomas: final results of a single institutional program. Am J Clin Oncol 2003 0.75
180 [Respiratory emergencies]. An Sist Sanit Navar 2004 0.75
181 Clinical and morphological recovery between two episodes of acute glomerulonephritis: a light and electron microscopic study with immunofluorescence. Clin Nephrol 1984 0.75
182 [Multiple myeloma with intracranial infiltration]. Med Clin (Barc) 1986 0.75
183 [Metastatic bone disease. Diagnosis and treatment]. An Sist Sanit Navar 2004 0.75
184 [Standard technic for the isolation and identification of the etiological agent of tuberculosis of the olive tree]. Microbiol Esp 1970 0.75
185 [Renal function in normal and malnourished children given different doses of vasopressin in continuous infusion]. Bol Med Hosp Infant Mex 1979 0.75
186 Die-off and survival of Pseudomonas aeruginosa in seawater. Zentralbl Bakteriol Mikrobiol Hyg B 1988 0.75
187 [Radiotherapy of mobile tumors]. An Sist Sanit Navar 2009 0.75
188 Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen. Int J Cancer 1997 0.75
189 [Nocturnal asthma: inhalation treatment with high doses of salbutamol and beclomethasone]. Rev Clin Esp 1986 0.75
190 Comparative studies of selective media for recovery of Staphylococcus aureus from natural waters. J Appl Bacteriol 1988 0.75
191 [Comparative study of the media of Monsu-agar and TCBS for the isolation of Vibrios from residual waters]. Rev Sanid Hig Publica (Madr) 1978 0.75
192 Die-off and survival of Pseudomonas aeruginosa in freshwater. Zentralbl Bakteriol Mikrobiol Hyg B 1988 0.75
193 [Acute glomerulonephritis in children. Prospective study of clinical, histopathologic and immunologic aspects]. Rev Chil Pediatr 1988 0.75
194 Synthesis of polyprenol-monophosphate- beta -galactose by acetobacter xylinum. Mol Cell Biochem 1977 0.75
195 [Acute dysphagia of oncological origin. Therapeutic management]. An Sist Sanit Navar 2004 0.75
196 [New developments in cancer immunotherapy]. Rev Med Suisse 2008 0.75